Proprietary Drug Levoleucovorin For Injection (formerly known as
ISO-Vorin™), A Novel Folate Analog, Is the
First New Oncology Drug Approved By the FDA in 2008
...
Spectrum Pharmaceuticals, Inc., (Nasdaq:SPPI) today announced that the
Therapeutic Product Directorate of Health Canada has approved the trials
to be conducted in Canada...
Spectrum Pharmaceuticals, Inc., (Nasdaq:SPPI) announced today that
Rajesh C. Shrotriya, M.D., President & Chief Executive Officer, will
present an overview of the...
Spectrum Pharmaceuticals, Inc. is engaged in the business of acquiring, developing and commercializing generic drug products that have a primary focus on the treatment of cancer and related...
Spectrum Pharmaceuticals, Inc., (Nasdaq: SPPI StocksForum) announced today that Rajesh C. Shrotriya, M.D., Chairman, President and Chief Executive Officer of Spectrum Pharmaceuticals, will present...